KRAS G12D degrader antibody conjugates (Polymed Biopharma)

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameKRAS G12D degrader antibody conjugates (Polymed Biopharma)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody degrader conjugate

Mechanisms of ActionKRAS G12D degraders

TargetsKRAS G12D

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesPolymed Biopharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesPolymed Biopharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A